title: Vitreous surgery in the management of chronic endogenous posterior uveitis.
abstract: OBJECTIVE
  There is evidence that pars plana vitrectomy (PPV) has a beneficial effect on the clinical course of chronic endogenous posterior uveitis (EPU) possibly by physically removing any resident inflammatory cells with the vitreous. We assessed the anatomical and therapeutic effects of PPV performed on patients with chronic EPU for any indication.
  
  
  METHODS
  Retrospective review of 41 eyes of 38 consecutive patients with EPU who underwent a PPV for any reason, over a 5-year period. The mean age of the patients was 36.2 years, 46% of the eyes had intermediate uveitis, 32% panuveitis, and 22% posterior uveitis. The visual acuity, disease activity, and the requirement for medications to control it were recorded for 12 months pre- and postoperatively.
  
  
  RESULTS
  Overall, 61% of the eyes gained more than 2 Snellen lines (P<0.001) and the incidence of cystoid macular oedema (CMO) significantly reduced from 44 to 20% (P<0.05). Postoperatively, there was a significant decrease in the recurrence rate of intermediate uveitis, posterior uveitis, and panuveitis (P<0.001). The use of systemic and local depot immunosuppressive agents did not change over the study period, although the use of topical agents increased (P<0.05).
  
  
  CONCLUSIONS
  PPV appears to have a beneficial effect on the clinical course of EPU in selected cases. This may be mediated by the physical clearance of inflammatory debris, the anti-inflammatory effect of replacing vitreous by aqueous humour, by a reduction of CMO and/or the anatomical correction of sight-threatening retinal pathology.
authors.affiliation: Moorfields Eye Hospital, London, UK.
authors.forename: R A
authors.initials: RA
authors.lastname: Scott
authors.forename: R J
authors.initials: RJ
authors.lastname: Haynes
authors.forename: G M
authors.initials: GM
authors.lastname: Orr
authors.forename: R J
authors.initials: RJ
authors.lastname: Cooling
authors.forename: C E
authors.initials: CE
authors.lastname: Pavésio
authors.forename: D G
authors.initials: DG
authors.lastname: Charteris
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002908:Chronic Disease; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D012163:Retinal Detachment / Q000503:physiopathology / Q000601:surgery; D012189:Retrospective Studies; D016896:Treatment Outcome; D015866:Uveitis, Posterior / Q000188:drug therapy / Q000503:physiopathology / Q000601:surgery*; D014792:Visual Acuity; D014821:Vitrectomy
chemical_list: D007166:Immunosuppressive Agents